January 2017

European experts highlight the potential of xenografts in personalized oncology

Leave a Comment / Transformation and Metastasis, Tumor and stromal chemoresistance  / By

European research lays the foundation for the development of new and ambitious research projects with xenografts derived from patients, preclinical models with great potential to advance research and treatment in cancer. The review article, published in Nature Reviews Cancer, is the result of the joint work of the European consortium of researchers EurOPDX, which includes […]

European experts highlight the potential of xenografts in personalized oncology Read More »

Inactivation of the B2M gene is recurrent in lung cancer and may condition the response to immunotherapy

Leave a Comment / Uncategorised / By

Researchers from the Genes and Cancer research group at the Bellvitge Biomedical Research Institute (IDIBELL) have identified inactivating mutations in a number of genes that code for HLA-I histocompatibility complex proteins, which are involved in the immune response and can condition the tesponse of lung cancer patients to immunotherapy. The study is a result of

Inactivation of the B2M gene is recurrent in lung cancer and may condition the response to immunotherapy Read More »

A bronchial GPS based on digital imaging for the early detection of lung cancer

Leave a Comment / Pneumology  / By

Researchers at the Center for Computer Vision and Bellvitge Hospital – IDIBELL have developed a technology that allows physicians to locate and move around the patients’ bronchi following a planned and localized route thanks to augmented reality techniques, video games and 3D modeling. The objective of this collaboration is to improve the existing technology in

A bronchial GPS based on digital imaging for the early detection of lung cancer Read More »

Scroll to Top